Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for nocturnal blood pressure elevations in idiopathic restless legs syndrome
2011-000053-23Phase 4Completed
- Sponsor
- UCB
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) comparing Rotigotine with Placebo (2 arms). Primary endpoint: Change from baseline in the number of elevations of systolic blood pressure during the night associated with periodic limb movements. Started May 2011; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2011-000053-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000053-23.